Serum neutrophil gelatinase-associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury

INTRODUCTION: Neutrophil gelatinase-associated lipocalin (NGAL) is a promising novel biomarker that correlates with the severity and outcome of acute kidney injury (AKI). However, its prognostic utility during the late course of AKI, especially in patients that require renal replacement therapy (RRT...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kümpers, Philipp, Hafer, Carsten, Lukasz, Alexander, Lichtinghagen, Ralf, Brand, Korbinian, Fliser, Danilo, Faulhaber-Walter, Robert, Kielstein, Jan T
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2010
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2875521/
https://ncbi.nlm.nih.gov/pubmed/20122150
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc8861
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars